Corbaux, Pauline http://orcid.org/0000-0001-8832-2562
Lardy-Cleaud, Audrey
Alexandre, Marie
Fontanilles, Maxime
Lévy, Christelle
Viansone, Alessandro Adriano
Mailliez, Audrey
Debled, Marc
Goncalves, Anthony
Le Du, Fanny
Lerebours, Florence
Ferrero, Jean-Marc
Eymard, Jean-Christophe
Mouret-Reynier, Marie-Ange
Petit, Thierry
Frenel, Jean-Sébastien
Dalenc, Florence
Courtinard, Coralie
Chaix, Marie
Bachelot, Thomas http://orcid.org/0000-0002-0866-9484
Funding for this research was provided by:
r&d unicancer
Article History
Received: 26 June 2021
Accepted: 6 September 2021
First Online: 23 October 2021
Declarations
:
: Dr Ledu has received compensation for her advisory role for Novartis, Lilly, Pfizer, Seatlle Genetics, Daiichi and Roche. She also has received research support from Pfizer, AstraZeneca, Novartis and Daiichi. Dr Frenel has received compensation for his advisory role for Novartis, Pfizer, Astra Zeneca, Lilly, Roche, Biocad, Daiichi, Tessaro, GSK and Pierre Fabre. Dr Bachelot has received compensation for his advisory role for Astra Zeneca, Novartis, Pfizer, Roche and SeaGen. He also has received research support from Roche, Pfizer, SeaGen and Astra Zeneca. Dr Corbaux, A. Lardy-Cléaud, Dr Alexandre, Dr Fontanilles, Dr Lévy, Dr Viansone, Dr Mailliez, Dr Debled, Dr Goncalves, Dr Lerebours, Dr Ferrero, Dr Eymard, Dr Mouret-Reynier, Dr Petit, Dr Dalenc, C. Courtinard and Dr Chaix declare no potential competing interests.
: The ESME database received approval from the French Data Protection Authority (<i>Commission Nationale de l’Informatique et des Libertés</i>, registration ID 1704113, authorization N DE-2013.-117). This work was approved by an independent ethics committee (<i>Comité de Protection des Personnes Sud-Est</i> II- 2015-79) which waived the requirement for dedicated informed consent. Approval of all patients for the use of their electronically recorded data had previously been obtained.